These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6333520)

  • 21. The retreat of Hemophilus influenzae type B invasive disease: analysis of an immunization program and implications for OTO-HNS.
    Beck RA; Kambiss S; Bass JW
    Otolaryngol Head Neck Surg; 1993 Oct; 109(4):712-21. PubMed ID: 8233509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprophylaxis for secondary Haemophilus influenzae type b disease.
    Cartwright KA; Begg NT; Hull D
    CDR (Lond Engl Rev); 1991 Jan; 1(1):R2-6. PubMed ID: 1669742
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemophilus influenzae type b in day care centers.
    Osterholm MT; Kuritsky JN; Murphy TV; Mead WC
    JAMA; 1985 May; 253(18):2647-8. PubMed ID: 3872948
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharyngeal carriage rates of Haemophilus influenzae, type b and non-b, and prevalence of ampicillin-resistant Haemophilus influenzae among healthy day-care children in central Massachusetts.
    Stephenson WP; Doern G; Gantz N; Lipworth L; Chapin K
    Am J Epidemiol; 1985 Nov; 122(5):868-75. PubMed ID: 3876764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive Haemophilus influenzae diseases and purulent meningitis in Taiwan.
    Wang CH; Lin TY
    J Formos Med Assoc; 1996 Aug; 95(8):599-604. PubMed ID: 8870429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Hightower AW; Broome CV
    JAMA; 1984 Dec; 252(23):3249-50. PubMed ID: 6334756
    [No Abstract]   [Full Text] [Related]  

  • 27. Patterns of Haemophilus influenzae type b invasive disease in New York State, 1987 to 1991: the role of vaccination requirements for day-care attendance.
    Schulte EE; Birkhead GS; Kondracki SF; Morse DL
    Pediatrics; 1994 Dec; 94(6 Pt 2):1014-6. PubMed ID: 7971041
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary rates of Haemophilus influenzae type b disease among day care contacts.
    Marks MI; Dorchester WL
    J Pediatr; 1987 Aug; 111(2):305-6. PubMed ID: 3497253
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of conjugated PRP vaccines on the incidence of invasive diseases caused by Haemophilus influenzae Type B in childhood].
    Desgrandchamps D; Schmid R; Zimmermann HP; Imahorn P; Kabus K; Schubiger G
    Schweiz Med Wochenschr; 1994 Apr; 124(14):575-82. PubMed ID: 8184297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Hemophilus influenzae disease in children. A 10-year retrospective study of an urban hospital population.
    Nesheim SR; Wilcox WD
    Clin Pediatr (Phila); 1986 Dec; 25(12):605-9. PubMed ID: 3490945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of H. influenzae in a day-care center.
    Akçakaya N; Torun MM; Söylemez Y; Sevme R; Cokuğraş H; Ergin S; Pinçe O; Eşkazan G
    Turk J Pediatr; 1996; 38(3):289-93. PubMed ID: 8827896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rifampin prophylaxis v placebo for household contacts of children with Hemophilus influenzae type b disease.
    Murphy TV; Chrane DF; McCracken GH; Nelson JD
    Am J Dis Child; 1983 Jul; 137(7):627-32. PubMed ID: 6602542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More on rifampin prophylaxis against Haemophilus influenzae b in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1988 Jan; 318(1):48-9. PubMed ID: 3257291
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology of Haemophilus influenzae type B disease among Navajo Indians.
    Coulehan JL; Michaels RH; Hallowell C; Schults R; Welty TK; Kuo JS
    Public Health Rep; 1984; 99(4):404-9. PubMed ID: 6431489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pediatric surveillance of invasive infections caused by Haemophilus influenzae type b in children in the period following introduction of vaccination].
    Conyn-van Spaendonck MA; Suijkerbuijk AW; Hirasing RA; van Pelt W
    Ned Tijdschr Geneeskd; 1995 Apr; 139(17):885-90. PubMed ID: 7739737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin.
    Yogev R; Melick C; Kabat K
    Pediatrics; 1981 Mar; 67(3):430-3. PubMed ID: 6972517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 38. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1986 Apr; 255(15):1990-2. PubMed ID: 3485727
    [No Abstract]   [Full Text] [Related]  

  • 39. Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains.
    Resman F; Ristovski M; Ahl J; Forsgren A; Gilsdorf JR; Jasir A; Kaijser B; Kronvall G; Riesbeck K
    Clin Microbiol Infect; 2011 Nov; 17(11):1638-45. PubMed ID: 21054663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
    Cochi SL; Broome CV; Hightower AW
    JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.